Scantox Acquires DuplexSeq™ Nonclinical Genomics Safety Business from TwinStrand Biosciences
PR Newswire —
Global expansion of advanced mutagenesis testing services supports regulatory genetic toxicology and next-generation genomic safety assessment EJBY, Denmark, Feb. 26, 2026 /PRNewswire/ -- Scantox Group today announced it has acquired the nonclinical genomic safety business of TwinStrand...